AcquisitionOther
AbbVie acquired Apogee Therapeutics
Public deal record from 8-K. The source names the buyer and target, and terms are shown only when the filing or announcement discloses them.
Deal tape row
AbbVie -> Apogee Therapeutics · $10.9 billion
To add diverse pipeline of clinical-stage assets targeting inflammatory and immunological diseases.
Open source record (SEC) ↗